Stockholders’ Equity (Tables)

9 Months Ended

Sep. 30, 2022

Stockholders' Equity Note [Abstract]

Schedule of fair value of options granted

	Original			Exchanged
Exercise price	$	6.65		$	2.546
Term (years)		3.67			5.0
Expected stock price volatility		116.2	%		120.2	%
Risk-free rate of interest		3.16	%		2.98	%

	For the Three Months Ended September 30,			For the Nine Months Ended September 30,
	2022			2022
Exercise price	$	2.91 – 3.48		$	2.55 – 6.45
Term (years)		5.04 – 7.00			5.00 – 10.00
Expected stock price volatility		114.8% – 119.9	%		114.5% – 121.2	%
Risk-free rate of interest		3.2% – 3.5	%		2.9% – 3.5	%

Schedule of stock option activity

						Weighted
						Average
				Weighted		Remaining
				Average		Contractual
	Number of			Exercise		Life
	Shares			Price		(in years)
Outstanding as of December 31, 2021		—		$	—		—
Granted		9,479,883			2.43
Exercised		(1,535,406	)		0.001
Cancelled		(1,180,812	)		6.65
Outstanding as of September 30, 2022		6,763,665			2.24		4.9
Warrants vested and exercisable as of September 30, 2022		6,763,665		$	2.24		4.9

								Weighted
								Average
				Weighted				Remaining
				Average		Total		Contractual
	Number of			Exercise		Intrinsic		Life
	Shares			Price		Value		(in years)
Outstanding as of December 31, 2021		780,640		$	0.01	$	532,787		8.1
Granted		768,613			6.10		—		—
Forfeited / cancelled		—			—		—		—
Exercised		(165,452	)		0.01		573,465		—
Outstanding as of September 30, 2022		1,383,801			3.40	$	1,044,282		8.6
Options vested and exercisable as of September 30, 2022		847,081		$	3.13	$	735,622		8.4

Schedule of stock-based compensation expense

	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
	2022		2021		2022		2021
General and administrative	$	255,115	$	9,337	$	1,193,743	$	33,213
Research and development		74,694		19,971		602,525		72,740
Total	$	329,809	$	29,308	$	1,796,268	$	105,953